Alector Inc (NASDAQ:ALEC)
| 16.29 Delayed Data As of May 07 |  -0.68 / -4.01%Today’s Change | 9.12 Today|||52-Week Range 34.89 | +7.67% Year-to-Date |
Latest ALEC News | Press Releases
| Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates May 05 / Zacks.com - Paid Partner Content | Analysts Estimate Alector (ALEC) to Report a Decline in Earnings: What to Look Out for May 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.97 |
| Today’s open | 17.19 |
| Day’s range | 16.17 - 17.29 |
| Volume | 30,886 |
| Average volume (3 months) | 616,511 |
| Market cap | $1.6B |
Data as of 4:00pm ET, 05/07/2021
Growth & Valuation
| Earnings growth (last year) | -43.31% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -31.53% |
| Revenue growth (last year) | -0.57% |
| P/E ratio | NM |
| Price/Sales | 55.76 |
| Price/Book | 5.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUPHAurinia Pharmaceutic... | -2.19 | -17.75% |
| PTGXProtagonist Therapeu... | +1.21 | +4.32% |
| PGENPrecigen Inc | -0.09 | -1.36% |
| CDMOAvid Bioservices Inc | +0.33 | +1.65% |
Data as of 5:49pm ET, 05/07/2021
Financials
| Next reporting date | August 17, 2021 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $21.1M |
| Annual profit (last year) | -$190.2M |
| Net profit margin | -901.64% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
